The mutation status (-mut) of the genes encoding isocitrate dehydrogenase (IDH) 1/2 is of central importance for the differentiation of low-grade to higher-grade gliomas, as low-grade gliomas present higher IDH-mut rates than high-grade gliomas [68]. The gene discussed is IDH3A; the disease is central nervous system cancer.